Salute e Benessere

New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS…

More than 92% of schizophrenia patients taking TEV- ' 749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication 1 New data from UZEDY ®(risperidone) evaluated predictors of response in schizophrenia with efficacy observed across patient demographic and clinical characteristics in the Phase 3 RISE trialTeva continues its commitment to generating clinical insights that help advance and support optimal treatment...
Nasdaq GlobeNewswire
31/03/2025

Modern Meadow's Sustainable Biomaterial Selected by Designer Karmuel Young for…

Organized by the Shanghai Fashion Designers Association and yehyehyeh, the 2025 Sustasia Fashion Prize is designed to accelerate sustainable practices and innovation in Asia's fashion industry. By providing a monetary award and industry support, the prize encourages designers to combine sustainable principles, innovative materials and new techniques into their work. The eight prize finalists from across Asia presented their final works on March 28 to a panel of judges who assessed based on…
PR Newswire
31/03/2025

Kindeva Appoints Daniel J. Speciale as the New Chief Financial Officer (CFO)

Mr. Speciale has nearly 20 years of financial leadership and deep healthcare and pharmaceuticals. Most recently, Mr. Speciale served as Senior Vice President, Finance— Controller, and Chief Accounting Officer at Vantive, where he played a key role in establishing financial strategy as the business separated from Baxter in a $3.8 billion sale to Carlyle. Previously, he held senior financial roles at Mallinckrodt, including Senior Vice President, Finance and CFO of the Specialty Generics division…
PR Newswire
31/03/2025

Sandoz strengthens its balance sheet by issuing new bonds to repay spin-off term…

MEDIA RELEASENOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN New USD 2.0 billion multi-currency revolving credit facility (RCF) in place to further strengthen Sandoz balance sheet and liquidityNew facility replaces initial and unutilized USD 1.25 billion RCF, in place since spin-off in 2023Dual-tranche CHF 400m and single-tranche EUR 500 million bonds issuedProceeds used to fully repay USD 750 million equivalent in USD and EUR term loans and extend...
Nasdaq GlobeNewswire
31/03/2025

TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously…

Media Release COPENHAGEN, Denmark; March 31, 2025 TIVDAK ®is the first and only antibody-drug conjugate (ADC) approved to treat recurrent or metastatic cervical cancer with disease progression on or after systemic therapyIn the global Phase 3 innovaTV 301 clinical trial TIVDAK demonstrated superior overall survival compared to chemotherapyTIVDAK is approved for the treatment of recurrent or metastatic cervical cancer in the European Union, United States and Japan...
Nasdaq GlobeNewswire
31/03/2025

Zelluna ASA [ZLNA]: Registration of reverse share split

Reference is made to the stock exchange notice published by the Zelluna ASA (the " Company ") on 27 March 2025 with key information concerning a reverse share split in the ratio of 10:1.The reverse share split has today been registered with the Norwegian Register of Business Enterprises. After the registration of the reverse share split, the new number of outstanding shares in the Company is 20,227,066, each with a par value of NOK 1.For further information, please contact:Hans...
Nasdaq GlobeNewswire
31/03/2025

Sports Medicine Market will reach at a CAGR of 8.2% from 2023 to 2031

Know about the future of Sports Medicine Market and what makes it a Booming industry according to following research report
DLR
31/03/2025

US Biomarkers Market worth US$34.3 billion by 2029 with 10.8% CAGR |…

Browse in-depth TOC on "US Biomarkers Market" Browse in-depth TOC on "US Biomarkers Market" 150 - Tables 53 – Figures The consumables segment accounted for the largest share by product & service segment in the US biomarkers market in 2023. By product & service, the US biomarkers market is categorized into consumables, services, and software. The consumables are further sub-segmented into assay kits, reagents & chemicals, columns & filters. The consumables...
PR Newswire
31/03/2025

Raythink Debuts at Hannover Messe 2025

The most impressive product is the newly launched wireless thermal camera for smartphones called IX2 Air. It weighs only 130 grams and can transmit images at a distance of up to 8 meters, featuring clear images and accurate temperature measurement. With its companion app enabling real-time analysis and data transmission, the device can be widely used in electrical maintenance, equipment inspection, HVAC leak detection, and other fields. In addition, the handheld thermal products for industrial…
PR Newswire
31/03/2025

Clinical Trial Supplies Market worth $8.18 billion in 2030 with 8.9% CAGR |…

Browse in-depth TOC on "Clinical Trial Supplies Market"480 - Tables48 - Figures410 - Pages Browse in-depth TOC on "Clinical Trial Supplies Market" 480 - Tables 48 - Figures 410 - Pages By services segment,the services segment is sub-segmented into Logistics & distribution services, storage & retention services, packaging, labelling and blinding services, manufacturing services, comparator sourcing services and other services. The logistics & distribution…
PR Newswire
31/03/2025

U.S. Ambulatory EHR Market to Reach $3.97 Billion by 2031, Growing at 5.8% CAGR…

Key Market Drivers and Trends Key Market Drivers and Trends The U.S. ambulatory EHR market is experiencing significant growth due to increasing government support for EHR adoption, the rising preference for ambulatory care over inpatient hospitalization, and the growing need among healthcare organizations to optimize operational costs. The transition from paper-based health records to digital platforms is enhancing care coordination, reducing errors, and improving overall efficiency in...
PR Newswire
31/03/2025

Following a planned interim analysis in the PROCEED trial Lundbeck expands the…

Despite the advancements in migraine treatment, there remains a significant unmet need in migraine management, with an estimated 2.5 to 3.0 million patients in the G7 countries who are inadequately treated with currently approved treatments. Lu AG09222 has, through its binding to PACAP, the potential to become a first in class migraine preventive treatment. Despite the advancements in migraine treatment, there remains a significant unmet need in migraine management, with an estimated 2.5 to 3...
PR Newswire
31/03/2025

Sobi publishes Annual and sustainability report for 2024

The report includes the audited Annual report and the Sustainability report, which is Sobi's statutory sustainability report in accordance with the Swedish Annual Accounts Act and based on GRI Standards 2021, inspired by the European Sustainability Reporting Standards (ESRS). The report includes the audited Annual report and the Sustainability report, which is Sobi's statutory sustainability report in accordance with the Swedish Annual Accounts Act and based on GRI Standards 2021, inspired by...
PR Newswire
31/03/2025

IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

The Company's audited consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 and accompanying management's discussion and analysis (the "Q4 MD&A"), together with its Annual Report on Form 20-F, can be accessed by visiting the Company's website at https://investors.imcannabis.com/, and its SEDAR+ and EDGAR profiles at www.sedarplus.ca, and http://www.sec.gov/edgar, respectively. The Company's audited consolidated financial statements for the…
PR Newswire
31/03/2025

Transactions in connection with share buy-back program

Company Announcement COPENHAGEN, Denmark; March 31, 2025 – Genmab A/S (Nasdaq: GMAB).On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025.The following transactions were executed under the program from March 26 to March 28, 2025: Trading Platform...
Nasdaq GlobeNewswire
31/03/2025

Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the…

The independent data monitoring committee (IDMC) considered VCN-01 to be well tolerated in metastatic PDAC patients treated with standard-of-care chemotherapy gemcitabine/nab-paclitaxel /nab-paclitaxel) and the adverse event (AE) profile was as expected for the patient population and the medications being studied.The IDMC, composed of key opinion leaders in pancreatic cancer and oncolytic viruses, reviewed clinical data from the complete safety population of 101 patients enrolled across 5...
Nasdaq GlobeNewswire
31/03/2025

Human Frontier Science Program: Fellowships Awarded to 60 Pioneering…

Postdoctoral scientists from these nations to receive 2025 HFSP Fellowships: Postdoctoral scientists from these nations to receive 2025 HFSP Fellowships: Online Booklet Lists Winners: The 2025 HFSP Fellowship awards reflect the ingenuity and drive for discovery of the next generation of researchers. HFSP reviewed proposals from 541 applicants. To read the abstracts of the 60 awardees, click:2025 HFSP Fellowships Awardees. To find individual scientists, click:Index by Country...
PR Newswire
31/03/2025

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term shelf stability for approvalDaily administration to patients via ampoules can minimize risk of contaminationLONDON and NEW YORK, March31, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for...
Nasdaq GlobeNewswire
31/03/2025

Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra…

Inspired by the legendary 'You Can't See Me' catchphrase, the Sunscreen You Can't See campaign reinforces that while you may not see Ultra Sheer ® Sunscreen on your skin, the high-SPF mineral formula is working hard to protect you from the harshest UV rays. Joining Cena in the campaign is dermatologist and skin cancer surgeon Dr. Neera Nathan. Inspired by the legendary 'You Can't See Me' catchphrase, the Sunscreen You Can't See campaign reinforces that while you may not see Ultra Sheer®...
PR Newswire
31/03/2025

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create…

The acquisition is supported by 65 Equity Partners, a global investment firm dedicated to supporting family-owned businesses, founders, and entrepreneurs. As part of the transaction, 65 Equity Partners becomes a c.40% shareholder alongside the Braglia family who retain majority ownership. The acquisition is supported by 65 Equity Partners, a global investment firm dedicated to supporting family-owned businesses, founders, and entrepreneurs. As part of the transaction, 65 Equity Partners…
PR Newswire
31/03/2025

Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for…

"Optimizing enzymes for industrial-scale production requires precision, speed, and innovation, and our collaboration with Bonumose exemplifies this," said Akbar Vahidi, Chief Technology Officer of Allozymes. "By leveraging our microfluidics-based protein engineering platform, we have been able to rapidly enhance key enzymes, significantly improving the process efficiency and scalability. The early results are promising, and we are confident that this partnership will unlock new…
PR Newswire
31/03/2025

Transactions under Novonesis' share buyback program

Please read the announcement in PDF Attachment 2025_15_Share_buyback_program
Nasdaq GlobeNewswire
31/03/2025

Reaffirming Leadership: Medit's Strong Presence at IDS 2025

Introducing Medit's Advanced Digital Solutions Introducing Medit's Advanced Digital Solutions Engaging Events & Expert Lectures Medit's Scanning Game event drew significant attention, allowing attendees to experience Medit's fast and intuitive scanning technology in an interactive challenge. Additionally, 11 experts in digital dentistry hosted daily Power Lectures, sharing their expertise and real-world applications of Medit's software. These sessions provided valuable insights...
PR Newswire
31/03/2025

Coway Holds 36th Annual General Meeting to Further Strengthen Shareholder Trust…

Shareholders also rejected Align Partners Capital Management Inc.'s ("Align Partners") proposal to introduce a cumulative voting system. A Coway official stated, "Our shareholders have reaffirmed that the current board operation ensures sufficient operational independence and transparency, making it suitable for ongoing sustainable growth and shareholder value enhancement." Shareholders also rejected Align Partners Capital Management Inc.'s ("Align Partners")…
PR Newswire
31/03/2025
Altri  Comunicati